Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants First trial of a new live attenuated Mycobacterium tuberculosis [...]
TBVI is pleased to announce the TBVI annual meeting 2020 in Les Diablerets. The meeting will be held from 27th to 29th of January 2020. As in previous years, the meeting will bring together the [...]
The VALIDATE Network aims to accelerate vaccine development for globally significant diseases caused by complex neglected intracellular pathogens. Our initial focus is on TB, leishmaniasis, [...]
True to the World Tuberculosis Day 2019 theme ‘It’s time!’ TBVI continues its efforts to sustain its unique collaborative research infrastructure with the aim to develop new, effective, [...]
From 28th to 31st January 2019 in Les Diablerets Switzerland, the TBVI symposium and TBVAC2020 annual meeting brought together 120 scientists and policy makers from 70 research institutes, [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: 0031 (0)6 1099 5196
